Skip to Content

Clinical Trial Details

TEMPO

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator (TEMPO)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Atrial Fibrillation
Study Type: Interventional
Phase: Phase II
Study Start Date: 01/05/2015
Study Completion Date: 12/30/2016

This study is to evaluate the effect of eleclazine (GS-6615) compared to placebo on the overall occurrence of appropriate implantable cardioverter-defibrillator (ICD) interventions (antitachycardia pacing [ATP] or shock) in adults with ICD or cardiac resynchronization therapy-defibrillator (CRT-D).

NCT Number
NCT02104583
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Gilead Sciences
Participant Eligibility
  • Age: 18 - 80
  • Gender: Male, Female

Location

  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!